Skip to main content
Account

Peer review reports

From: Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis

Original Submission
12 Apr 2017 Submitted Original manuscript
7 May 2017 Reviewed Reviewer Report - Alessandro Morabito
8 May 2017 Reviewed Reviewer Report - Koji Takeda
24 May 2017 Reviewed Reviewer Report - M. Hassan Murad
21 Jul 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 2
21 Jul 2017 Submitted Manuscript version 2
2 Aug 2017 Reviewed Reviewer Report - Koji Takeda
11 Aug 2017 Reviewed Reviewer Report - M. Hassan Murad
24 Aug 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 3
24 Aug 2017 Submitted Manuscript version 3
1 Sep 2017 Reviewed Reviewer Report - M. Hassan Murad
8 Sep 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 4
8 Sep 2017 Submitted Manuscript version 4
27 Sep 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 5
27 Sep 2017 Submitted Manuscript version 5
Publishing
9 Oct 2017 Editorially accepted
30 Oct 2017 Article published 10.1186/s12916-017-0954-x

Learn about peer review

Back to article page

Navigation